Method for preventing nasolacrimal duct obstruction
AssigneeKem Holdings
InventorKenneth Eli Morgenstern
Life of this patent
Estimating the term…
Abstract
The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer. The method includes administering an effective amount of perchlorate anion to the eyes of the patient.
Claims20
A method for preventing nasolacrimal duct obstruction that may occur upon radioactive iodine treatment in a patient receiving radioactive iodine for treatment of thyroid cancer, the method comprising administering to the eyes of said patient a therapeutically effective amount of perchlorate anion.
A method for preventing nasolacrimal duct obstruction that may occur upon radioactive iodine treatment in a patient receiving radioactive iodine for treatment of breast cancer, the method comprising administering to the eyes of said patient a therapeutically effective amount of perchlorate anion.
A method for preventing nasolacrimal duct obstruction in a patient receiving radioactive iodine, the method comprising administering to the eyes of said patient a therapeutically effective amount of perchlorate anion.
Dependencies are inferred from the claim text.